Lumexa Imaging Holdings, Inc.

Lumexa Imaging Holdings, Inc.

NNASDAQ:LMRI
14.79
USD
-0.02
(-0.14%)
-0.19EPS
984.64MMarket Cap
Apr 01Next Earn
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
13.48
10.03
14.41
11.63
Basic EPS, GAAP
-1.76
-1
-0.66
-0.19
Free Cash Flow per Basic Share
0.19
0.14
-0.09
0.6
Dividend per Share
- -
- -
- -
- -
Book Value per Share
2.1
1.71
6.1
6.6
Tangible Book Value per Share
-7.06
-7.34
-2.73
-2.21
Basic Weighted Avg Shares
69
95
71
91
Sales/Revenue/Turnover
936
949
1,023
1,056
Operating Margin (%)
-1.37
-1.71
2.61
0.71
Depreciation Expense
72
57
55
58
Net Income, GAAP
-122
-94
-47
-17
Effective Tax Rate (%)
- -
- -
- -
- -
Profit Margin (%)
-13.06
-9.92
-4.6
-1.61
Working Capital
6
-1
48
95
LT Debt
1,268
1,274
924
932
Total Equity
198
162
586
634
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)
- -
-52.27
-12.6
-4.26

Capital Structure

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
41
42
45
LT Borrowings
817
820
822
LT Finance Leases
110
113
110
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
96
96
96
Market Capitalization
826
1,084
985

Working Capital

USD

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
222
256
278
Cash, Cash Equivalents & STI
51
70
90
Accounts Receivable, Net
134
141
140
Inventories
- -
- -
- -
Total Current Liabilities
158
178
183
Payables & Accruals
86
86
80
ST Debt
41
42
45
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
262.58%
Free Cash Flow
- -
- -
-149.43%
Net Income, GAAP
- -
- -
-49.94%
Sales/Revenue/Turnover
- -
- -
7.82%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
248
949
2025
245
251
259
268
1,023
2026
253
264
272
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
-0.26
-1
2025
-0.08
-0.08
-0.04
-0.38
-0.66
2026
0.02
0.03
0.07
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Caitlin Zulla
Full Time Employees
5,019
Sector
Health services
Industry
Medical/Nursing services
Address
4200 Six Forks Road Raleigh NC United States 27609
IPO Date
Dec 11, 2025
Business
Lumexa Imaging Holdings, Inc. (Nasdaq: LMRI) operates the second-largest outpatient imaging center network in the United States, providing diagnostic imaging services through 184 centers across 13 states, including 85 joint ventures with health systems as of September 30, 2025. The company offers advanced imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET) scans; basic diagnostic services including X-rays, ultrasounds, and mammograms; and operates via wholly owned centers, variable interest entities, and joint ventures, generating management fees from unconsolidated affiliates. Lumexa Imaging utilizes a scalable integrated technology platform with third-party AI solutions to enhance efficiency and clinical quality, serving a diversified referral network of approximately 100,000 physicians across 29,000 practices, with centers featuring convenient retail settings and extended hours. Founded in 2018 through a partnership between Charlotte Radiology and private equity firm Welsh, Carson, Anderson & Stowe, Lumexa Imaging is headquartered in Raleigh, North Carolina. The company has rapidly expanded from 20 centers in 2018 to its current footprint via 20 acquisitions and 41 de novo openings, targeting high-growth metropolitan areas with favorable demographics. It employs over 5,000 team members and a network of more than 1,000 subspecialized radiologists, performing over 4 million outpatient studies annually. In recent developments, Lumexa Imaging completed its initial public offering on December 10, 2025, pricing 25 million shares at $18.50 to raise $462.5 million, with proceeds primarily allocated to repay a portion of its $1.2 billion term loan debt. Effective July 8, 2025, its affiliate US Radiology Specialists Holdings, LLC rebranded to Lumexa Imaging Equity Holdco, LLC, aligning with the company's unified identity. These moves support ongoing growth in the diagnostic imaging sector, where 58% of consolidated revenue derives from commercial payors.

Company News

  • Lumexa Imaging Opens Three New Imaging Centers in November

  • Lumexa Imaging Expands Partnership with Advocate Health Through New Illinois Joint Venture

  • Lumexa Imaging Holdings, Inc. (LMRI) Q3 2026 Earnings Call Transcript

  • What Lumexa Imaging (LMRI) Said on Its Q3 Earnings Call

  • Lumexa Imaging Announces Third Quarter 2026 Results

  • Lumexa Imaging Announces Third Quarter 2026 Earnings Conference Call Date

  • Lumexa Imaging (NASDAQ:LMRI) versus DocGo (NASDAQ:DCGO) Head-To-Head Comparison

  • Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) Receives Average Recommendation of “Buy” from Analysts

  • Lumexa Imaging Holdings, Inc. $LMRI Shares Purchased by Squarepoint Ops LLC

  • Lumexa (LMRI) Upgraded to Buy: Here's What You Should Know

  • BlackRock Inc. Takes $15.77 Million Position in Lumexa Imaging Holdings, Inc. $LMRI

  • Lumexa Imaging Announces Participation in Upcoming Investor Conferences

  • Wall Street Analysts See a 36.88% Upside in Lumexa (LMRI): Can the Stock Really Move This High?

  • Lumexa Imaging Holdings, Inc. (LMRI) Q2 2026 Earnings Call Transcript

  • Lumexa Imaging Q2 Earnings Call Highlights

  • Lumexa Imaging Announces Second Quarter 2026 Results

  • Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date

  • 4 Medical Products Stocks Poised to Win Despite Industry Headwinds

  • Wall Street Analysts Think Lumexa (LMRI) Could Surge 44.08%: Read This Before Placing a Bet

  • Wall Street Analysts Believe Lumexa (LMRI) Could Rally 73.25%: Here's is How to Trade